Advertisement

Alcohol and Substance Use Disorders in Women

  • Silvia Brasiliano
  • Adriana Trejger Kachani
  • Fabio Carezzato
  • Patricia Brunfentrinker Hochgraf
Chapter
  • 27 Downloads

Abstract

This chapter presents an overview of substance use–related disorders among the female population. It starts justifying the needs to study this specific group of individuals. It describes the diagnostic criteria and the prevalence of this problem in Brazil and in the world, which indicates an increased rate of these disorders among women. It also discusses the differences and similarities between women and men regarding genetics, drug use initiation, and the evolution of the disease, as well as detailing physical, psychic, and social complications. It emphasizes the nutritional aspects of this group and ends up pointing out prevention and treatment strategies that could be most effective for this particular population.

Keywords

Gender Women’s health Substance use disorder Alcohol use disorder Gender differences Substance abuse treatment Treatment barriers Treatment outcome Women Female 

References

  1. 1.
    Lal R, Deb KS, Kedia S. Substance use in women: status and future directions. Indian J Psychiatry. 2015;57(suppl 2):S275–85.PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    National Institute on Drug Abuse (NIDA). Substance use in women. NIDA Research Series. 2016. Available from: http://www.drugabuse.gov/publications/research-reports/substance-use-in-women/summary.
  3. 3.
    Battjes RL, Onken LS, Delany PJ. Drug abuse treatment entry and engagement: report of a meeting on treatment readiness. J Clin Psychol. 1999;55:643–57.PubMedCrossRefGoogle Scholar
  4. 4.
    Health Canada. Best practices – treatment and rehabilitation for women with substance use problems. Ottawa: Publications Health Canada; 2001.Google Scholar
  5. 5.
    McCrady BS, Epstein EE, Cook S, Jensen N, Hildebrant T. A randomized trial of individual and couple behavioral alcohol treatment for women. J Counsult Clin Psychol. 2009;77:243–56.CrossRefGoogle Scholar
  6. 6.
    Hochgraf PB. Alcoolismo feminino: comparação das características sociodemográficas e padrão de evolução entre homens e mulheres alcoolistas [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 1995.Google Scholar
  7. 7.
    Edwards G. O tratamento do alcoolismo. 2a edição. Livraria Martins Fontes: São Paulo; 1987.Google Scholar
  8. 8.
    American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders, fifth edition. DSM-5. Washington, DC: APA; 2013.CrossRefGoogle Scholar
  9. 9.
    Goodman DJ, Wolff KB. Screening for substance abuse in women’s health: a public health imperative. J Midwifery Women Health. 2013;58:278–87.CrossRefGoogle Scholar
  10. 10.
    Blume S. Chemical dependency in women: important issues. Am J Drug Alcohol Abuse. 1990;16:297–307.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Sallaup TV, Vaaler AE, Iversen VC, Guzey C. Challenges in detecting and diagnosing substance use in women in the acute psychiatric department: a naturalistic cohort study. BMC Psychiatry. 2016;16:406. PubMed: PMD 5114750.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Thurang GA, Fagerberg I, Palmstierna T, Tops AB. Women’s experiences of caring when in treatment for alcohol dependency. Scand J Caring Sci. 2010;24:700–6.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Bold KW, Epstein EE, McCrady BS. Baseline health status and quality of life after alcohol treatment for women with alcohol dependence. Addict Behav. 2017;64:35–41.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Hochgraf PB, Andrade AG. A questão do gênero nas farmacodependências. In: Cordás TA, Salzano FT, editors. Saúde mental da mulher. São Paulo: Editora Atheneu; 2004. p. 85–103.Google Scholar
  15. 15.
    Slade T, Chapman C, Swift W, Keyes K, Tonks Z, Teesson M. Birth cohort trends in the global epidemiology of alcohol use and alcohol-related harms in men and women: systematic review and metaregression. BMJ Open. 2016;6:e011827. PubMed; PMC 5093369.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Hasin DS, Grant BF. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. Soc Psychiatry Epidemiol. 2015;50(11):1609–40.CrossRefGoogle Scholar
  17. 17.
    Grant BD, Goldstein RB, Tulshi DS, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Epidemiology of DSM-5 alcohol use disorder. JAMA Psychiat. 2015;72:757–66.CrossRefGoogle Scholar
  18. 18.
    Dawson DA, Goldstein RB, Saha TD, Grant BF. Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend. 2015;148:56–61.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Arch Gen Psychiatry. 2007;64:566–76.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM IV alcohol abuse and dependence in the United States. Arch Gen Psychiatry. 2007;64:830–42.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014. Available from: http://www.store.samhsa.gov.Google Scholar
  22. 22.
    Laranjeira R supervisão e cols. II Levantamento Nacional de Álcool e Drogas (LENAD). São Paulo: Instituto Nacional de Ciências e Tecnologia para Políticas Públicas de Álcool e outras Drogas (INPAD), UNIFESP; 2014.Google Scholar
  23. 23.
    Prescott CA, Aggen SH, Kendler KS. Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of U.S. twins. Alcohol Clin Exp Res. 1999;23:1136–44.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Ehlers CL, Gizer IR, Vieten C, Gilder A, Gilder DA, Stouffer GM, et al. Age at regular drinking, clinical course, and heritability of alcohol dependence in the San Francisco Family Study: a gender analysis. Am J Addict. 2010;19:101–10.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Munn-Chernoff MA, Duncan AE, Grant JD, Wade TD, Agrawal A, Bucholz KK, et al. A twin study of alcohol dependence, binge eating, and compensatory behaviors. J Stud Alcohol Drugs. 2013;74:664–73.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Verhulst B, Neale MC, Kendler KS. The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies. Psychol Med. 2015;45:1061–72.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Messas GP, Vallada Filho HP. O papel da genética na dependência do álcool. Rev Bras Psiquiatr. 2004;26(supl 1):54–8.CrossRefGoogle Scholar
  28. 28.
    Walter H, Gutierrez K, Ramskogler K, Hertling I, Dvorak A, Lesch OM. Gender-specific differences in alcoholism: implications for treatment. Arch Womens Ment Health. 2003;6:253–8.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatry Clin North Am. 2010;33:339–55.CrossRefGoogle Scholar
  30. 30.
    National Institute on Drug Abuse (NIDA). Sex and gender differences in substance use. 2015. Available from: http://ww.drugabuse.goc/publications/drugfacts/substance-use-in-women.
  31. 31.
    Brienza RS, Stein MD. Alcohol use disorders in primary care: do gender-specific differences exist? J Gen Intern Med. 2002;17:387–97.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Holdcraft LC, Iacono WG. Cross-generational effects on gender differences in psychoactive drug abuse and dependence. Drug Alcohol Depend. 2004;74:147–58.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Corsi KF, Rinehart DJ, Kwiatkowski CF, Booth RE. Case management outcomes for women who use crack. J Evid Based Soc Work. 2010;7:30–40.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating n-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017;26:136–44.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Green CA, Polen MR, Dickinson DM, et al. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abus Treat. 2002;23:285–95.CrossRefGoogle Scholar
  36. 36.
    Johnson PB, Richter I, Kleber HD, et al. Telescoping of drinking-related behaviors: gender, racial/ethnic and age comparisons. Subst Use Misuse. 2005;40:1139–51.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Keyes KM, Grant BF, Hasin DS. Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend. 2008;93:2121–9.CrossRefGoogle Scholar
  38. 38.
    Bravo F, Gral A, LLgoña A, Colon J. Gender differencesin the long-term outcome of alcohol dependence treatment: an analysis of twenty-years prospective follow up. Drug Alcohol Depend. 2013;32:3881–388.Google Scholar
  39. 39.
    Choi S, Adams SM, Morse SA, MacMaster S. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders. Subst Use Misuse. 2015;50:653–63.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry. 1993;150(11):1707–11.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Anker JJ, Carroll ME. Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci. 2010;8:73–96.CrossRefGoogle Scholar
  42. 42.
    Graham K, Wilsnack R, Dawson D, Vogeltanz N. Should alcohol consumption measures be adjusted for gender differences? Addiction [Internet]. 1998;93(8):1137–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9813895.CrossRefGoogle Scholar
  43. 43.
    Sellers B. Unique effects of alcoholism in women. Prim Psychiatry. 2005;12(1):47–51.Google Scholar
  44. 44.
    Thomasson HR. Gender differences in alcohol metabolism. Physiological responses to ethanol. Recent Dev Alcohol. 1995;12:163–79.PubMedGoogle Scholar
  45. 45.
    Loft S, Olesen K-L, Døssing M. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol [Internet]. 1987;22(10):1251–6. Available from:  https://doi.org/10.3109/00365528708996472.CrossRefGoogle Scholar
  46. 46.
    Miller MA, Weafer J, Fillmore MT. Special issue: gender & alcohol. Gender differences in alcohol impairment of simulated driving performance and driving-related skills. Alcohol Alcohol. 2009;44(6):586–93.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Bosron WF, Li T-K. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases, and their relationship to alcohol metabolism and alcoholism. Hepatology [Internet]. 1986;6(3):502–10. Available from:  https://doi.org/10.1002/hep.1840060330.CrossRefGoogle Scholar
  48. 48.
    Baraona E, Abittan CS, Dohmen K, Moretti M, Pozzato G, Chayes ZW, et al. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res [Internet]. 2001;25(4):502–7. Available from:  https://doi.org/10.1111/j.1530-0277.2001.tb02242.x.PubMedCrossRefGoogle Scholar
  49. 49.
    Müller C, Besonderheiten G. Liver, alcohol and gender. Wien Med Wochenschr. 2006;156(19–20):523–6.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Wilsnack SC, Wilsnack LW. Focus on: women and the costs of alcohol use. Alcohol Res. 2013;35:219–28.PubMedGoogle Scholar
  51. 51.
    Chiva-blanch G, Arranz S, Lamuela-raventos RM, Estruch R. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors : evidences from human studies. Alcohol Alcohol. 2013;48(3):270–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Fernandez-Sola J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol [Internet]. 2015;12(10):576–87. Available from:  https://doi.org/10.1038/nrcardio.2015.91.CrossRefGoogle Scholar
  53. 53.
    Zhang SM, Lee IM, Manson JE, Cook NR, Willet WC, Buring JE. Alcohol consumption and breast cancer risk in the Women’s Health Study. Am J Epidemiol. 2007;165:667–76.PubMedCrossRefGoogle Scholar
  54. 54.
    Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res [Internet]. 2005;29(5):896–901. Available from:  https://doi.org/10.1097/01.ALC.0000164376.69978.6B.CrossRefGoogle Scholar
  55. 55.
    Demirakca T, Ende G, Kämmerer N, Welzel-Marquez H, Hermann D, Heinz A, et al. Effects of alcoholism and continued abstinence on brain volumes in both genders. Alcohol Clin Exp Res. 2011;35(9):1678–85.PubMedGoogle Scholar
  56. 56.
    Becker JB. Sex differences in addiction. Dialogues Clin Neurosci. 2016;18:395–402.PubMedPubMedCentralGoogle Scholar
  57. 57.
    Evans SM, Haney M, Foltin RW. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology. 2002;159(4):397–406.PubMedCrossRefGoogle Scholar
  58. 58.
    Lukas SE, Sholar M, Lundahl LH, Lamas X, Kouri E, Wines JD, et al. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology. 1996;125(4):346–54.PubMedCrossRefGoogle Scholar
  59. 59.
    Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Kaufman MJ, Levin JM, et al. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology. 1999;21(2):294–303.PubMedCrossRefGoogle Scholar
  60. 60.
    Lynch WJ, Kalayasiri R, Sughondhabirom A, Pittman B, Coric V, Morgan PT, et al. Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict Biol. 2008;13(3–4):403–10.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Fox HC, Garcia M, Kemp K, Milivojevic V, Kreek MJ, Sinha R. Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependent individuals. Psychopharmacology. 2006;185(3):348–57.PubMedCrossRefGoogle Scholar
  62. 62.
    Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, et al. Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry. 1996;39(2):147–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Levin JM, Holman BL, Mendelson JH, Teoh SK, Garada B, Johnson KA, et al. Gender differences in cerebral perfusion in cocaine abuse: technetium-99m-HMPAO SPECT study of drug-abusing women. J Nucl Med. 1994;35(12):1902–9.PubMedGoogle Scholar
  64. 64.
    King DE, Herning RI, Gorelick DA, Cadet JL. Gender differences in the EEG of abstinent cocaine abusers. Neuropsychobiology. 2000;42(2):93–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Ide JS, Zhang S, Hu S, Sinha R, Mazure CM, Li CR. Cerebral gray matter volumes and low-frequency fluctuation of BOLD signals in cocaine dependence: duration of use and gender difference. Drug Alcohol Depend [Internet]. 2014;134(1):51–62. Available from:  https://doi.org/10.1016/j.drugalcdep.2013.09.004.CrossRefGoogle Scholar
  66. 66.
    Gill JR, Hayes JA, Marker E, Stajic M, others. Ecstasy (MDMA) deaths in New York City: a case series and review of the literature. J Forensic Sci. 2002;47(1):121–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Green AR, Shea EO, Colado MI. A review of the mechanisms involved in the acute MDMA (ecstasy) -induced hyperthermic response. Eur J Pharmacol. 2004;500:3–13.PubMedCrossRefGoogle Scholar
  68. 68.
    Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology. 2004;173(3–4):242–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Rosenson J. Patterns of ecstasy-associated hyponatremia in California. Ann Emerg Med. 2007;49(2):164–71.PubMedCrossRefGoogle Scholar
  70. 70.
    Wyeth RP, Mills EM, Ullman A, Kenaston MA, Burwell J, Sprague JE. The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences. Toxicol Appl Pharmacol [Internet]. 2009;235(1):33–8. Available from:  https://doi.org/10.1016/j.taap.2008.12.003.CrossRefGoogle Scholar
  71. 71.
    Cunningham M. Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure. Intensive Crit Care Nurs. 1997;13(4):216–23.PubMedCrossRefGoogle Scholar
  72. 72.
    Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3, 4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol. 2008;3(6):1852–60.PubMedCrossRefGoogle Scholar
  73. 73.
    Budisavljevic MN, Stewart L, Sahn SA, Ploth DW. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine (“Ecstasy”) abuse. Am J Med Sci. 2003;326(2):89–93.PubMedCrossRefGoogle Scholar
  74. 74.
    Simmler LD, Hysek M, Liechti ME. Sex differences in the effects of MDMA (Ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab. 2011;96(September):2844–50.PubMedCrossRefGoogle Scholar
  75. 75.
    Lindenberg S, Agren G. Mortality among male and female hospitalized alcoholics in Stockholm 1962–1983. Br J Addict. 1988;83:1193–200.CrossRefGoogle Scholar
  76. 76.
    Roerecke M, Rehn J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(3):906–19.  https://doi.org/10.1093/ije/dyu018.CrossRefPubMedGoogle Scholar
  77. 77.
    Zaleski M, Laranjeira RR, Marques ACPR, Ratto L, Romano M, Alves HNP, et al. Diretrizes da Associação Brasileira de estudos do álcool e outras drogas (ABEAD) para diagnóstico e tratamento de comorbidades psiquiátricas e dependência de álcool e outras substâncias. Res Bras Psiquiatria. 2006;28(2):142–8.CrossRefGoogle Scholar
  78. 78.
    Mohs ME, Watson RR, Leonard-Green T. Nutritional effects of marijuana, heroin, cocaine, and nicotine. J Am Diet Assoc. 1990;90(9):1261–7.PubMedGoogle Scholar
  79. 79.
    American Dietetic Association (ADA). Position of the American Dietetic Association: nutrition intervention in treatment and recovery from chemical dependency. J Am Diet Assoc. 1990;90(9):1274–7.Google Scholar
  80. 80.
    Reis NT, Rodrigues CSC. Nutrição clínica no alcoolismo. Rio de Janeiro: Rubio; 2003.Google Scholar
  81. 81.
    Kachani AT, Brasiliano S, Hochgraf PB. O impacto do consumo alcoólico no ganho de peso. Rev Psiq Clin. 2008;35:21–4.Google Scholar
  82. 82.
    Guimarães NS, Nemer ASA, Fausto MA. Influência do consumo de álcool nas alterações antropométricas: uma revisão sistemática. Nutr Clin Diet Hosp. 2013;33(3):68–76.Google Scholar
  83. 83.
    Mukamai KJ, Clowry CM, Murray MM, Hendriks HF, Rimm EB, Sink KM, Adebamowo CA, Dragsted LO, Lapinski PS, Lazo M, Krystal JH. Moderate alcohol consumption and chronic disease: the case for a long-term trial. Alcohol Clin Exp Res. 2016;40(11):2283–91.CrossRefGoogle Scholar
  84. 84.
    Li R, Wang Q, Wang L, Mao J, Qian J. Pellagra secondary medication and alcoholism: a case report and review of the literature. Nutr Clin Pract. 2016;31(6):785–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Neuman MG, French SW, Zakhari S, Malnick S, Seltz HK, Cohen LB, Salaspuro M, Volnea-Griffin A, Barash A, Kirpich IA, Thomes PG, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M. Alcohol, microbiome, life style influence and non-alcoholic organ damage. Exp Mol Pathol. 2017;102(1):162–80.PubMedCrossRefGoogle Scholar
  86. 86.
    Prioste RN, Casagranda CI, Húngaro CM, Nunes DA, Bueno EA, Bordin L, Marchiotto O Jr, Nicolau PFM, Lozano RI, Antunes VAC, Hida WT, Martinez TIR. Alterações no metabolismo de homocisteína induzida por aguardente de cana de açúcar em alcoólatras. J Bras Patolog Med Lab. 2003;39:203–6.Google Scholar
  87. 87.
    Toffolo MCF, Pereira I d S, Silva KAL, Marliére CA, Nemer AS d A. Escolha de alimentos durante a abstinência alcoólica: influência na fissura e no peso corporal. J Bras Psiquiatr. 2011;60(4):341–6.CrossRefGoogle Scholar
  88. 88.
    Okuda LS, Melissa T, Kachani AT. Dependência de outras drogas. In: Cordás TA, Kachani AT, editors. Nutrição em Psiquiatria. São Paulo: Artmed; 2010. p. 234–46.Google Scholar
  89. 89.
    Kachani AT, Okuda LS, Barbosa ALR, Brasiliano S, Hochgraf PB. Disordered eating em mulheres dependentes de álcool e outras drogas. In: VIII Congresso Brasileiros de Transtornos Alimentares e Obesidade, 2009. June 11–13. São Paulo: Unifesp; 2009.Google Scholar
  90. 90.
    Munn-Chernoff MA, Baker JH. A primer on the genetics of comorbid eating disorders and substance use disorders. Eur Eat Disord Rev. 2016;24(2):91–100.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Cowan J, Devine C. Food, eating, and weight concerns of men in recovery from substance addiction. Appetite. 2008;50(1):33–42.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Brasiliano S. Comorbidade entre dependência de substâncias psicoativas e transtornos alimentares: perfil e evolução de mulheres em um tratamento específico para dependência química [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 2005.Google Scholar
  93. 93.
    Stickel A, Rohdermann M, Landes T, Engel K, Banas R, Heinz A, Muller CA. Changes in nutrition-related behaviors in alcohol-dependent patients after outpatient detoxification: the role of chocolate. Subst Use Misuse. 2016;51(5):545–52.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Warren CS, Lindsay AR, White EK, Claudat K, Velasquez SC. Weight-relate concerns related to drug use for women in substance abuse and relationship with eating pathology. J Subst Abus Treat. 2013;44(5):494–501.CrossRefGoogle Scholar
  95. 95.
    Drach LL, Maher JE, Braun MJ, Murray SL, Sazie E. Substance use, disordered eating, and weight gain: describing the prevention and treatment needs of incarcerated women. J Correct Health Care. 2016;22(2):139–45.PubMedCrossRefPubMedCentralGoogle Scholar
  96. 96.
    Heidari M, Ghodusi M. Relationship of assess self-esteem and locus of control with quality of life during treatment stages in patients referring to drug addiction rehabilitation centers. Mater Sociomed. 2016;28(4):263–7.PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Curran HV, Robjant K. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy. J Psychopharmacol. 2006;20:425–31.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Herzog DB, Franko DL, Dorer DJ, Keel PK, Jackson S, Manzo MP. Drug abuse in women with eating disorders. Int J Eat Disord. 2006;39:364–8.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Leddy M, Schulkin J, Power M. Consequences of high incarceration rate and high obesity prevalence on the prison system. J Correctional Health Care. 2009;15:318–27.CrossRefGoogle Scholar
  100. 100.
    DeHovitz JA, Kelly P, Feldman J, Sierra MF, Clarke L, Bromberg J, et al. Sexually transmitted diseases, sexual behavior and cocaine use in inner-city women. Am J Epidemiol. 1994;140:1125–34.PubMedCrossRefGoogle Scholar
  101. 101.
    Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin. 1999;22(2):241–52.Google Scholar
  102. 102.
    United Nations Office on Drugs and Crime (UNODC). Substance abuse treatment and care for women: case studies and lessons learned. Vienna: United Nations Publication; 2004.Google Scholar
  103. 103.
    Stein ND, Cyr MC. Women and substance abuse. Med Clin North Am. 1997;81:979–98.PubMedCrossRefGoogle Scholar
  104. 104.
    Teoh SK, Mello NK, Mendelsohn JH. Effects of drugs of abuse on reproductive function in women and pregnancy. In: Watson RR, editor. Addictive behaviors in women. Totowa: Humana Press; 1994. p. 437–73.CrossRefGoogle Scholar
  105. 105.
    Ramsey SE, Bell KM, Engler PA. Human immunodeficiency virus risk behavior among female substance abusers. J Addict Dis. 2010;29(2):192–9.PubMedPubMedCentralCrossRefGoogle Scholar
  106. 106.
    Corsi KF, Rinehart DJ, Kwiatkowski CF, Booth RE. Case management outcomes for women who use crack. J Evid Base Soc Work. 2010;7(1-2):30–40.CrossRefGoogle Scholar
  107. 107.
    Jansson LM, Velez MJ. Infants of drug-dependents mothers. Pediatr Rev. 2011;32:5–13.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Howell EM, Heiser N, Harrington M. A review of recent findings on substance abuse treatment for pregnant women. J Subst Abus Treat. 1999;16:195–219.CrossRefGoogle Scholar
  109. 109.
    Riley EP, Infant A, Warren RR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011;21:73–80.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    May PA, Blankenship J, Marais AS, Gossage JP, Kalberg WO, Joubert B, et al. Maternal alcohol consumption producing fetal spectrum disorders (FASD): quantity, frequency and time of drinking. Drug Alcohol Depen. 2013;133:502–12.CrossRefGoogle Scholar
  111. 111.
    Bíblia. A Bíblia Sagrada: antigo e novo testamento. Tradução de João Ferreira de Almeida. Brasília: Sociedade Bíblia do Brasil; 1969.Google Scholar
  112. 112.
    Terplan M, Wright T. Effects of cocaine and amphetamine use during pregnancy on the newborn: myth versus reality. J Addict Disord. 2011;30:1–5.CrossRefGoogle Scholar
  113. 113.
    Silva SA, Pires AP, Gouveia MJ. Toxicodependência e maternidade: uma revisão da literatura. Psicol Clin. 2015;27:83–100.CrossRefGoogle Scholar
  114. 114.
    Silva MB, Kruno RB. Consequências do uso do crack para a gestante e seu recém-nascido: uma revisão integrativa da literatura. Revista CIPPUS – Unilasalle. 2014;3:110–20.Google Scholar
  115. 115.
    Becker JB, McClellan ML, Reed BG. Sex differences, gender and addiction. J Neurosci Res. 2017;95:136–47.PubMedPubMedCentralCrossRefGoogle Scholar
  116. 116.
    Kendler KS, Lönn SL, Salvatore J, Sundquist J, Sundquist K. Effect of marriage on risk for onset of alcohol use disorder: a longitudinal and co-relative analysis in a Swedish national sample. Am J Psychiatr. 2016;173(9):911–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Guimarães ABP. Mulheres dependentes de álcool: levantamento transgeracional do genograma familiar [tese]. São Paulo: Faculdade de Medicina, Universidade de São Paulo; 2009.Google Scholar
  118. 118.
    Devries KM, Child JC, Bacchus LJ, Mak J, Falder G, Graham K, et al. Intimate partner violence victimization and alcohol consumption in women: a systematic review and meta-analysis. Addiction. 2014;109:379–91.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Brasiliano S, Hochgraf PB. Women group psychotherapy: goals and characteristics in addressing the specific needs of alcohol and other drug dependence women. In: Abstracts of the 42nd International Institute on the Prevention and Treatment of Dependencies. Malta: International Council on Alcohol and Addictions; 1998.Google Scholar
  120. 120.
    Comfort M, Kaltenbach KA. Predictors of treatment outcomes for substance-abusing women: a retrospective study. Subst Abuse. 2000;21(1):33–45.Google Scholar
  121. 121.
    Galera SAF, Roldan MCB, O’Brien B. Mulheres vivendo no contexto de drogas (violência) – papel maternal. Rev Latin-Am Enf. 2005;13:1142–7.CrossRefGoogle Scholar
  122. 122.
    Hser YI, Huang D, Teruya C, et al. Gender comparisons of drug abuse treatment outcomes and predictors. Drug Alcohol Depend. 2003;72:255–64.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Barcinski M. Protagonismo e vitimização na trajetória de mulheres envolvidas na rede do tráfico de drogas no Rio de Janeiro. Ciên Saúde Coletiva. 2009;14:577–86.CrossRefGoogle Scholar
  124. 124.
    Jarvis TJ, Copeland J, Walton L. Exploring the nature of the relationship between child sexual abuse and substance use among women. Addiction. 1998;93:865–75.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Kendler KS, Bulik CM, Silberg J, Hetterna JS, Myers J, Prescott CA. Childhood sexual abuse and adult psychiatric and substance use disorders in women. An epidemiological and cotwin control analysis. Arch Gen Psychiatry. 2000;57:953–9.PubMedCrossRefPubMedCentralGoogle Scholar
  126. 126.
    Helzer JE, Przybeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219–24.PubMedCrossRefPubMedCentralGoogle Scholar
  127. 127.
    Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol andther drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. J Am Med Assoc. 1990;264:2511–8.CrossRefGoogle Scholar
  128. 128.
    Bucholz KK. Nosology and epidemiology of addictive disorders and their comorbidity. Psychiatric Clin North Am. 1999;22:221–40.CrossRefGoogle Scholar
  129. 129.
    Kessler RC, Crum RM, Warner LA, Nelson CB, Schulemberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with others psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313–21.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Torrens SM, Gilshrist G, Domingo-Salvany A, The PsyCo Barcelona Group. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend. 2011;113:147–56.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Tucci ML. Fatores associados ao uso de substâncias psicoativas: história de abuso e negligência na infância, história familiar e comorbidades psiquiátricas [tese]. São Paulo: Escola Paulista de Medicina, Universidade Federal de São Paulo; 2003.Google Scholar
  132. 132.
    Olsson TM, Fridell M. Women with comorbid substance dependence and psychiatric disorders in Sweden: a longitudinal study of hospital care utilization costs. BMC Health Serv Res. 2015;15:224.PubMedPubMedCentralCrossRefGoogle Scholar
  133. 133.
    Resko SM, Brown S, Mendoza NS, Crosky S. Perceived treatments needs among women with co-occurring substance use disorders and PTSD. J Dual Diagn. 2016;12:271–81.PubMedCrossRefGoogle Scholar
  134. 134.
    Ruglass LM, Shevorykin AS, Brezing C, Hu MC, Hien DA. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. J Subst Abus Treat. 2017;80:45–51.CrossRefGoogle Scholar
  135. 135.
    Goldstein RB, Dawson DA, Chou P, Grant BE. Sex differences in prevalence and comorbidity of alcohol and drug use disorders: results from wave 2 of the National Epidemiological Survey on Alcohol and Related Conditions. J Stud Alcohol Drugs. 2012;73:938–50.PubMedPubMedCentralCrossRefGoogle Scholar
  136. 136.
    Malik K, Chand PK, Marimuthu P, Suman LN. Addiction severity and comorbidity among women with alcohol use disorders: a hospital-based study from India. Asian J Psychiatr. 2017;28:67–72.PubMedCrossRefGoogle Scholar
  137. 137.
    Gadalla T, Piran N. Co-occurrence of eating disorders and alcohol use disorders in women: a meta-analysis. Arch Women’s Mental Health. 2007;10:133–40.CrossRefGoogle Scholar
  138. 138.
    Calero-Elvira A, Krug I, Davis K, Lopez C, Fernandez-Aranda F, Treasure J. Meta-analysis on drugs in people with eating disorders. Eur Eat Disord Rev. 2009;17:243–59.PubMedCrossRefGoogle Scholar
  139. 139.
    Killeen T, Brewerton BD, Campbell A, Cohen LR, Hien DA. Exploring the relationship between eating disorders and substance use severity in women with comorbid PTSD ads substance use disorders. Am J Drug Alcohol Abuse. 2015;41:547–52.PubMedPubMedCentralGoogle Scholar
  140. 140.
    Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, Hien D. Survey of eating disorders symptoms among women in treatment for substance abuse. Am J Addict. 2010;19:245–51.PubMedPubMedCentralCrossRefGoogle Scholar
  141. 141.
    Harrop EN, Marlatt GA. The comorbidity of substance use disorders and eating disorders in women: prevalence, etiology and treatment. Addict Behav. 2010;35:392–8.PubMedCrossRefGoogle Scholar
  142. 142.
    Chen LY, Strain EC, Crum RM, Motjabai R. Gender differences in substance abuse treatment and barriers to care among persons with substance use disorders with and without comorbid major depression. J Addict Med. 2013;7:325–34.PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Kolla NJ, Vander Maas M, Toplak ME, Erickson PG, Mann RE, Seely J, Vingilis E. Adult attention deficit hyperactivity disorder symptoms profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey. BMC Psychiatr. 2016;16:1–9.CrossRefGoogle Scholar
  144. 144.
    Innamorati M, Lester D, Amore M, Girardi P, Tatarelli R, Pompili M. Alcohol consumption predicts the EU suicide rates in young women aged 15-29 years but not in men: analysis of trends and differences among early and new EU countries since 2004. Alcohol. 2010;44:463–9.PubMedCrossRefGoogle Scholar
  145. 145.
    Sugarman DE, Wigderson SB, Iles BR, Kaufman JS, Garrett M, Fitzmaurice E, et al. Measuring affiliation in group therapy for substance use disorders in the Women’s Recovery Group Study: does it matter whether the group is all-women or mixed gender? Am J Addict. 2016;25:573–80.PubMedPubMedCentralCrossRefGoogle Scholar
  146. 146.
    Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29:19–53.PubMedCrossRefGoogle Scholar
  147. 147.
    Greenfield SF, Brooks AJ, Gordon SM, Green CA, Kropp F, McRugh RK, et al. Substance abuse treatment entry, retention and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86:1–21.PubMedCrossRefGoogle Scholar
  148. 148.
    Brown VB, Melchior LA, Waite-O’Brien N, Huba GJ. Effects of women-sensitive, long-term residential treatment on psychological functioning of diverse populations of women. J Subst Abus Treat. 2002;23:133–44.CrossRefGoogle Scholar
  149. 149.
    Grosso JA, Epstein EE, McCrady BS, Gaba A, Cook S, Backer-Fulghum LM, Graf FS. Women’s motivators for seeking treatment for alcohol use disorders. Addict Behav. 2013;38:2236–45.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Greenfield SF, Sugarman DE, Freid CM, Bailey GL, Crisafulli MA, Kaufman JS, et al. Group therapy for women with substance use disorders: results from the Women’s Recovery Group Study. Drug Alcohol Depend. 2014;142:245–53.PubMedPubMedCentralCrossRefGoogle Scholar
  151. 151.
    Davis S. Effects of chemical dependency in parenting women. In: Watson RR, editor. Addictive behaviors in women. Totowa: Humana Press; 1994. p. 381–412.CrossRefGoogle Scholar
  152. 152.
    Evans E, Li L, Pierce J, Hser YJ. Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs. J Subst Abus Treat. 2013;45:293–301.CrossRefGoogle Scholar
  153. 153.
    Greenfield SF, Trucco EM, McHugh RK, Lincoln M, Gallap RJ. The Women’s Recovery Group: a stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug Alcohol Depend. 2007;90:39–47.PubMedPubMedCentralCrossRefGoogle Scholar
  154. 154.
    Grella CE, Joshi V, Hser YI. Program variation in treatment outcomes among women in residential drug treatment. Eval Rev. 2000;24:364–83.PubMedCrossRefPubMedCentralGoogle Scholar
  155. 155.
    Brasiliano S, Hochgraf PB. Adesão de mulheres a um programa específico de tratamento. Álcool e Drogas – Revista da Abead. 1999;2:43–9.Google Scholar
  156. 156.
    Brasiliano S. Psicoterapia psicanalítica de grupo para mulheres drogadictas: o que há do feminino? In: Baptista M, Cruz MS, Matias R, editors. Drogas e pós-modernidade: prazer, sofrimento e tabu, v. 1. Rio de Janeiro: Editora da Universidade do Rio de Janeiro; 2003. p. 199–205.Google Scholar
  157. 157.
    Brasiliano S, Hochgraf PB. Drogadicção feminina: a experiência de um percurso. In: Silveira DX, Moreira FG, editors. Panorama atual de drogas e dependências. São Paulo: Editora Atheneu; 2006. p. 289–95.Google Scholar
  158. 158.
    Orwin R, Francisco L, Bernichon T. Effectiveness of women’s substance abuse treatment programs: a meta-analysis national evaluation data services, center for substance abuse treatment. Center for Substance Abuse Treatment. SAMHSA: Arlington; 2001.Google Scholar
  159. 159.
    Hochgraf PB. Especificidades das mulheres farmacodependentes. In: Programa Oficial e Temas Livres do I Congresso de Saúde Mental da Mulher. Lemos Editorial e Gráficos: São Paulo; 2000.Google Scholar
  160. 160.
    McMahon TJ, Luthar SS. Women in treatment – within-gender differences in the clinical presentation of opioid-dependent women. J Nerv Ment Dis. 2000;188:679–87.PubMedCrossRefGoogle Scholar
  161. 161.
    Niv N, Hser YJ. Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes. Drug Alcohol Depend. 2007;87:194–201.PubMedCrossRefPubMedCentralGoogle Scholar
  162. 162.
    Duarte CE, Brasiliano S, Hochgraf PB. Comorbidade e adesividade a um tratamento específico. In: Livro de resumos do XIX Congresso Brasileiro de Psiquiatria – WPA Regional Meeting, v. 1. Rio de Janeiro: Associação Brasileira de Psiquiatria; 2000. p. 164.Google Scholar
  163. 163.
    Duarte CE, Ferreira RC, Milharcic SI, Brasiliano S, Hochgraf PB. A internação da mulher dependente química – aderência a um tratamento multidisciplinar específico. In: Programa Oficial e Temas Livres do I Congresso Brasileiro de Saúde Mental da Mulher. São Paulo: Lemos Editorial e Gráficos; 2000.Google Scholar
  164. 164.
    Gregorowski C, Seedat S, Jordan GP. A clinical approach to the assessment and management of comorbid eating disorders and substance use disorders. BMC Psychiatry. 2013;13:289.Google Scholar
  165. 165.
    Compton WM, Cottler LB, Jacobs JL, ArbiBen-Abdallah MS, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence outcomes. Am J Psychiatry. 2003;160:890–5.PubMedCrossRefGoogle Scholar
  166. 166.
    Evans E, Padwa H, Li L, Lin V, Hser YI. Heterogeneity of mental health service utilization and high mental health service use among women 8 years after initiating substance use treatment. J Subst Abus Treat. 2015;59:10–9.CrossRefGoogle Scholar
  167. 167.
    Patrick DD. Dual diagnosis: substance-related and psychiatric disorders. Nurs Clin North Am. 2003;38:67–73.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Silvia Brasiliano
    • 1
  • Adriana Trejger Kachani
    • 1
  • Fabio Carezzato
    • 1
  • Patricia Brunfentrinker Hochgraf
    • 1
  1. 1.Women Drug Dependent Treatment Center – Psychiatry Institute – Clinicas Hospital – Medical School – University of São PauloSão PauloBrazil

Personalised recommendations